We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Tetrahydrocurcumin (THC, a curcumin metabolite)
The main active metabolite of curcumin, sold as a colourless, more stable 'next-generation curcumin.' It's a genuine antioxidant and anti-inflammatory in the lab, but human evidence is almost non-existent — experimental, not a proven supplement.
What the evidence says
Most Tetrahydrocurcumin studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from medium-quality randomised trials published 2006–2026 with a typical study size of 19 participants.
Based on 20 studies · 1 RCT · 29 total participants
Confidence
Low confidenceBy outcome
2 more outcomes with fewer studies not shown.
Extensive, consistent preclinical evidence for antioxidant and anti-inflammatory activity across cell and animal models, but almost no human data — one 19-person open-label antidepressant-adjunct pilot and one small non-significant topical vitiligo study. No RCTs powered for clinical outcomes, and mechanistic reviews note curcumin is often the more potent parent compound. Scored Emerging.
Tetrahydrocurcumin (THC) is what the body makes when it reduces curcumin — the main coloured compound in turmeric. It's colourless, more water-stable than curcumin, and in many cell and animal studies shows antioxidant, anti-inflammatory, and metabolic activity through pathways like NF-κB, Nrf2, and AMPK.
Supplement marketers frame it as a 'more bioavailable, next-generation curcumin.' The honest picture is much more cautious: the vast majority of evidence is preclinical (test tubes and rodents), and head-to-head lab comparisons find curcumin is actually the more potent antioxidant for many targets — THC is not simply 'better curcumin.' Direct human data amounts to a single tiny open-label pilot (19 people) suggesting it might augment an antidepressant, and one small topical study for vitiligo that did not reach statistical significance.
Until real randomized trials exist, THC is best understood as a promising but experimental supplement rather than one with demonstrated benefits.
Scavenges reactive oxygen species and induces antioxidant enzymes (e.g. glutathione peroxidase) in cell and animal models — though curcumin itself is often the more potent radical scavenger.
Downregulates NF-κB signalling and inflammatory cytokines (TNF-α, IL-1β) in preclinical inflammation models.
Activates the Nrf2 pathway and modulates MAPK, PI3K/Akt/mTOR, and AMPK signalling in laboratory studies — the basis for most of its proposed metabolic and organ-protective effects.
THC is the reduced, colourless metabolite the body forms from curcumin. It is more water-stable, which is the rationale behind marketing it as a 'more bioavailable' alternative — a claim not yet validated by human pharmacokinetic outcomes.
How Tetrahydrocurcumin works — from molecular targets to health outcomes. Click an edge to see supporting research.This visualization is in beta — pathways are being refined and expanded.
Avoid — no safety data.
Discuss with a clinician before use given the theoretical antiplatelet effect of curcuminoids.
Prefer standardised curcumin, which has far more human evidence than THC.
Curcumin-type compounds may have mild antiplatelet activity; theoretical additive bleeding risk with warfarin, clopidogrel, or aspirin. No THC-specific data.
Preclinical glucose-lowering activity raises a theoretical additive risk with diabetes medications; unquantified in humans.
Curcuminoids can modulate drug-metabolising enzymes and transporters, potentially altering levels of some medications. THC-specific relevance is unknown.
Tip: Take with food; reduce dose
Tip: Human safety beyond short pilots is uncharacterised — use conservatively
The current evidence for Tetrahydrocurcumin is insufficient to assign an evidence score, based on 17 indexed studies. The main active metabolite of curcumin, sold as a colourless, more stable 'next-generation curcumin.' It's a genuine antioxidant and anti-inflammatory in the lab, but human evidence is almost non-existent — experimental, not a proven supplement. Representative study: PMID 42281524.
The commonly studied dose of Tetrahydrocurcumin is No established human dose. The one oral human pilot used 200 mg/day; supplement products typically supply 250–500 mg/day. Dosing is not evidence-based.. Individual needs vary — start at the lower end of the range and adjust based on how you respond.
Timing is flexible for Tetrahydrocurcumin — consistent daily use matters more than the time of day. As a lipophilic curcumin-type compound, taking it with a fat-containing meal is a reasonable default for absorption, but no human timing data exist.
Tetrahydrocurcumin is generally safe at recommended doses, with a few precautions worth noting. The most commonly reported side effects are unknown long-term effects, GI upset. Use caution if any of these apply to you: Pregnancy and breastfeeding (no safety data); Bleeding disorders or scheduled surgery (theoretical antiplatelet effect, by analogy to curcumin).
Alpha Lipoic Acid
Likely helpsUniversal antioxidant that works in both water and fat, supporting blood sugar control, nerve health, and cellular energy.
Nicotinamide Riboside
Mostly mechanism / observationalA vitamin B3 precursor that reliably raises cellular NAD+ levels and is well tolerated — but human trials have so far shown mostly null or mixed results on the functional outcomes (muscle, metabolism, blood pressure, cognition) that elevation is meant to drive.
Luteolin
Likely helpsA dietary flavonoid with anti-inflammatory effects in the lab. The honest verdict: the only direct human RCTs test PEA-luteolin combinations for post-COVID smell loss — isolated luteolin's anti-inflammatory, allergy, and brain claims rest on mechanism and reviews, not human trials, and its bioavailability is low.
CoQ10
Likely helpsA lipid-soluble antioxidant central to mitochondrial energy production, with the strongest trial support for fertility/IVF outcomes and heart failure.
Explore: Best supplements for Vitality & LongevityBest supplements for Focus, Memory & Mood
Reviewed by Dr. Baher Al Hakim · Last reviewed July 2026 · evidence from 20 studies · how we score · editorial policy
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.
Tap node to isolate • Pinch to zoom • Tap edge for research